Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M12,471Revenue $M3,050Net Margin (%)25.5Z-Score4.2
Enterprise Value $M12,902EPS $8.4Operating Margin %51.4F-Score8
P/E(ttm))16.0Cash Flow Per Share $8.0Pre-tax Margin (%)42.3Higher ROA y-yY
Price/Book6.810-y EBITDA Growth Rate %14.3Quick Ratio2.6Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %19.6Current Ratio3.2Lower Leverage y-yY
Price/Cash Flow12.2y-y EBITDA Growth Rate %250ROA % (ttm)17.0Higher Current Ratio y-yN
Dividend Yield %0.5Insider Buy (3m)1ROE % (ttm)45.2Less Shares Outstanding y-yY
Payout Ratio %8.0Shares Outstanding M74.9ROI % (ttm)5.1Gross Margin Increase y-yY

Gurus Latest Trades with BCR

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impact Price Range
(Average)*
Current Price Change from Averagedown Comment Current Shares
BCRJoel Greenblatt 2014-09-30 Add0.27%$142.3 - $153.13
($147.81)
$ 166.513%Add 470.83%229,325
BCRDonald Yacktman 2014-09-30 Reduce-0.15%$142.3 - $153.13
($147.81)
$ 166.513%Reduce -3.85%6,443,334
BCRYacktman Focused Fund 2014-09-30 Reduce-0.22%$142.3 - $153.13
($147.81)
$ 166.513%Reduce -6.52%2,150,000
BCRJohn Hussman 2014-09-30 Buy 0.18%$142.3 - $153.13
($147.81)
$ 166.513%New holding, 15000 sh.15,000
BCRRay Dalio 2014-09-30 Add0.04%$142.3 - $153.13
($147.81)
$ 166.513%Add 115.75%59,086
BCRYacktman Fund 2014-06-30 Reduce-0.12%$136.23 - $149.25
($142.86)
$ 166.516%Reduce -2.76%3,330,000
BCRVanguard Health Care Fund 2014-06-30 Reduce-0.28%$136.23 - $149.25
($142.86)
$ 166.516%Reduce -37.07%1,157,400
BCRRobert Olstein 2014-06-30 Add0.15%$136.23 - $149.25
($142.86)
$ 166.516%Add 26.67%38,000
BCRRay Dalio 2014-06-30 Reduce-0.02%$136.23 - $149.25
($142.86)
$ 166.516%Reduce -36.59%27,386
BCRJoel Greenblatt 2014-06-30 Add0.05%$136.23 - $149.25
($142.86)
$ 166.516%Add 187.29%40,174
BCRYacktman Focused Fund 2014-03-31 Reduce-0.91%$125.42 - $146.57
($137.91)
$ 166.521%Reduce -21.67%2,350,000
BCRVanguard Health Care Fund 2014-03-31 Add0.63%$125.42 - $146.57
($137.91)
$ 166.521%Add 505.6%1,839,200
BCRDonald Yacktman 2014-03-31 Reduce-0.51%$125.42 - $146.57
($137.91)
$ 166.521%Reduce -11.96%6,827,627
BCRRay Dalio 2014-03-31 Add0.03%$125.42 - $146.57
($138.12)
$ 166.520%Add 118.27%43,186
BCRRobert Olstein 2013-12-31 Reduce-0.11%$113.84 - $139.85
($132.09)
$ 166.526%Reduce -14.63%35,000
BCRYacktman Fund 2013-12-31 Reduce-0.45%$113.84 - $139.85
($132.09)
$ 166.526%Reduce -9.89%3,500,000
BCRYacktman Focused Fund 2013-12-31 Reduce-1.7%$113.84 - $139.85
($132.09)
$ 166.526%Reduce -29.91%3,000,000
BCRDonald Yacktman 2013-12-31 Reduce-1.09%$113.84 - $139.85
($132.09)
$ 166.526%Reduce -21.46%7,755,464
BCRVanguard Health Care Fund 2013-12-31 Buy 0.13%$113.84 - $139.85
($132.09)
$ 166.526%New holding, 303700 sh.303,700
BCRRay Dalio 2013-12-31 Reduce-0.01%$113.84 - $139.85
($132.09)
$ 166.526%Reduce -30.54%19,786
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BCR is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BCR John Hussman 2014-09-3015,0000.020.18New Buy
BCR Joel Greenblatt 2014-09-30229,3250.310.33+470.83%
BCR Ray Dalio 2014-09-3059,0860.080.07+115.75%
BCR Yacktman Fund 2014-09-303,250,0004.344-2.4%
BCR Donald Yacktman 2014-09-306,443,3348.63.8-3.85%
BCR Yacktman Focused Fund 2014-09-302,150,0002.873.3-6.52%
BCR Vanguard Health Care Fund 2014-09-301,039,1001.390.38-10.22%
BCR Robert Olstein 2014-09-3034,0000.050.63-10.53%
Premium Most recent portfolio changes are included for Premium Members only!


BCR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Lupisella Frank JrVice President and Controller 2014-10-30Sell5,980$160.23.93view
Luboff Sharon MGroup Vice President 2014-10-27Sell10,000$158.84.85view
Naughton Gail KDirector 2014-10-27Sell400$158.74.91view
RING TIMOTHY MChairman and CEO 2014-10-22Sell60,000$149.0711.69view
RING TIMOTHY MChairman and CEO 2014-10-06Sell60,000$14812.5view
WEILAND JOHN HPresident and COO 2014-09-10Sell27,179$149.511.37view
RING TIMOTHY MChairman and CEO 2014-09-02Sell10,228$148.8311.87view
KELLY BRONWEN KVP - Human Resources 2014-08-04Sell10,055$150.2510.82view
RING TIMOTHY MChairman and CEO 2014-08-01Sell10,231$149.0411.71view
Melcher David FDirector 2014-07-31Buy500$150.4910.64view

Press Releases about BCR :

    Quarterly/Annual Reports about BCR:

    News about BCR:

    Articles On GuruFocus.com
    Becton, Dickinson and Co. (BDX) Dividend Stock Analysis Nov 19 2014 
    Weekly 52-Week Highs Highlight: LBTYK, STZ, FISV, BCR Nov 09 2014 
    Dividend Aristocrats In Focus Part 19 of 54: CR Bard Oct 15 2014 
    Medtronic Inc. (MDT) Dividend Stock Analysis Sep 12 2014 
    Paulson, Mindich and Soros Bought Covidien; Should You? Sep 11 2014 
    No More a Simple Distributor Sep 07 2014 
    Becton, Dickinson and Co. (BDX) Dividend Stock Analysis May 30 2014 
    CR Bard Focuses on Small to Medium-Sized Deals Apr 04 2014 
    Yacktman Funds Comments on C.R. Bard Inc. Mar 12 2014 
    Yacktman Fund Comments on C.R. Bard Inc. Jan 30 2014 


    More From Other Websites
    BARD C R INC /NJ/ Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation... Nov 21 2014
    Invacare (IVC) Down to Strong Sell on Dismal Q3 Results Nov 20 2014
    Henry Schein Strong on Healthy Track Record, Fundamentals Nov 20 2014
    Bard to Present at the Piper Jaffray Healthcare Conference Nov 19 2014
    CR Bard (BCR) Scales 52-Week High on Strong Q3 Results Nov 19 2014
    LabCorp Shows Strength on Covance Buyout Plan, Robust Q3 Nov 17 2014
    Cramer: Stocks That Stand Out Nov 17 2014
    MWI Veterinary Beats Q4 Earnings & Sales yet Shares Fall Nov 12 2014
    Henry Schein Tops Q3 Earnings, Revenues; Shares Rally Nov 11 2014
    Steris Gains on Q2 Earnings and Revenue Beat; EPS View Up Nov 11 2014
    CareFusion Q1 Earnings, Revenues Rise and Beat Estimates Nov 07 2014
    Bard to Present at the Stifel Healthcare Conference Nov 05 2014
    Bard to Present at the Stifel Healthcare Conference Nov 05 2014
    Covidien to Sell Stellarex DCB to Spectranetics for $30M Nov 04 2014
    BARD C R INC /NJ/ Financials Oct 30 2014
    Today CR Bard (BCR) Hits New Lifetime High Oct 28 2014
    BARD C R INC /NJ/ Files SEC form 10-Q, Quarterly Report Oct 23 2014
    CR Bard Beats Q3 Earnings and Revenues, '14 View Raised Oct 23 2014
    C R Bard Inc Earnings Call scheduled for 5:00 pm ET today Oct 22 2014
    BARD C R INC /NJ/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Oct 22 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK